Olema Pharmaceuticals, Inc. (OLMA)
16.75
-4.80
(-22.27%)
USD |
NASDAQ |
Mar 09, 14:39
Olema Pharmaceuticals SG&A Expense (TTM) : 18.61M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Cogent Biosciences, Inc. | 63.58M |
| Corvus Pharmaceuticals, Inc. | 9.105M |
| Protagonist Therapeutics, Inc. | 44.85M |
| BridgeBio Pharma, Inc. | 531.22M |
| Oric Pharmaceuticals, Inc. | 33.19M |